Researcher
Weimiao Yu obtained his PhD degree from the National University of Singapore (NUS) in 2007, majoring in image processing and machine vision. He joined A*STAR’s Institute of Molecular and Cell Biology (IMCB) in 2007. Yu is currently heading the Computational & Molecular Pathology Lab (CMPL) to deepen and extend R&D collaborations with clinical and industry partners. His research interests are in computational biomedical image analysis and quantitative imaging informatics. To enhance the application of machine learning and AI in clinical diagnosis/prognosis, he co-founded a biotech company called A!maginostic Pte. Ltd. Researchers at a joint lab of excellence which Yu established between A!maginostic and IMCB conduct immunodiagnosis at the tissue level.
Related Articles
A collagen ‘highway’ for cancer
1 Feb 2021The structure of collagen fibers may play a key role in the spread of breast